Sterol regulators of cholesterol homeostasis and beyond: The oxysterol hypothesis revisited and revised

Progress in Lipid Research

Volumn 47, Issue 6, 2008, Pages 391-404

  Gill, Saloni ^a   Chow, Renee ^a   Brown, Andrew J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

24(S); 25 epoxycholesterol; 27 Hydroxycholesterol; Desmosterol; Kandutsch; Lanosterol; Niemann Pick type C disease; Oxysterols; Sulfation

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; OXYSTEROL; SONIC HEDGEHOG PROTEIN; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN;

CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; ENDOPLASMIC RETICULUM; ENZYME STRUCTURE; ENZYME SYNTHESIS; FEEDBACK SYSTEM; HOMEOSTASIS; HUMAN; HYPOTHESIS; LIPID DEGRADATION; LIPID METABOLISM; NIEMANN PICK DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; CHOLESTEROL; HEDGEHOG PROTEINS; HOMEOSTASIS; HUMANS; LIPID METABOLISM; NIEMANN-PICK DISEASE, TYPE C; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEINS; STEROLS;

ERINACEIDAE;

EID: 53149118574     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2008.04.002     Document Type: Review

References (144)

1. Simons K., and Ikonen E. How cells handle cholesterol. Science 290 (2000) 1721-1726
2. Brown M.S., and Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997) 331-340
3. Kandutsch A.A., Chen H.W., and Heiniger H.J. Biological activity of some oxygenated sterols. Science 201 (1978) 498-501
4. Massey J.B. Membrane and protein interactions of oxysterols. Curr Opin Lipidol 17 (2006) 296-301
5. Fieser L.F., and Fieser M. Steroids (1959), Reinhold Publishing Corporation, New York
6. Chevreul M.E. Examen des graisses d'homme, de mouton, de boeuf, de jaguar et d'oie. Ann Chim Phys 2 (1816) 33
7. Smith L.L. Cholesterol autoxidation (1981), Plenum Press, New York
8. Brown A.J., and Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 142 (1999) 1-28
9. Javitt N.B. Oxysterols: novel biologic roles for the 21st century. Steroids 73 (2008) 149-157
10. Schroepfer Jr. G.J. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80 (2000) 361-554
11. van Reyk D.M., Brown A.J., Hult'en L.M., Dean R.T., and Jessup W. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Rep 11 (2006) 255-262
12. Bodin K., Bretillon L., Aden Y., Bertilsson L., Broome U., Einarsson C., et al. Antiepileptic drugs increase plasma levels of 4β-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem 276 (2001) 38685-38689
13. Björkhem I. Rediscovery of cerebrosterol. Lipids 42 (2007) 5-15
14. Javitt N.B. 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles. J Lipid Res 43 (2002) 665-670
15. Wilson L.D., and Harding B.W. Oxidation of 20α-hydroxycholesterol by adrenal cortex mitochondria. J Biol Chem 248 (1973) 9-14
16. Hume R., Kelly R.W., Taylor P.L., and Boyd G.S. The catalytic cycle of cytochrome P-450scc and intermediates in the conversion of cholesterol to pregnenolone. Eur J Biochem 140 (1984) 583-591
17. Russell D.W. Oxysterol biosynthetic enzymes. Biochim Biophys Acta 1529 (2000) 126-135
18. Lange Y., Ory D.S., Ye J., Lanier M.H., Hsu F.-F., and Steck T.L. Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and HMG-CoA reductase. J Biol Chem 283 (2008) 1445-1455
19. Hutson J.C. Physiologic interactions between macrophages and Leydig cells. Exp Biol Med 231 (2006) 1-7
20. Schoenheimer R., and Breusch F. Synthesis and destruction of cholesterol in the organism. J Biol Chem 103 (1933) 439-448
21. Gould R.G., Taylor C.B., Hangerman J.S., Warner I., and Campbell D.J. Cholesterol metabolism I. Effect of dietary cholesterol on the synthesis of cholesterol in dog tissue in vitro. J Biol Chem 201 (1952) 519-528
22. Tomkins G.M., Sheppard H., and Chaikoff I.L. Cholesterol synthesis by liver IV. Suppression by steroid administration. J Biol Chem 203 (1953) 781-786
23. Kandutsch A.A., and Chen H.W. Inhibition of sterol synthesis in cultured mouse cells by 7α-hydroxycholesterol, 7β-hydroxycholesterol, and 7-ketocholesterol. J Biol Chem 248 (1973) 8408-8417
24. Brown M.S., Ho Y.K., and Goldstein J.L. The low-density lipoprotein pathway in human fibroblasts: relation between cell surface receptor binding and endocytosis of low-density lipoprotein. Ann NY Acad Sci 275 (1976) 244-257
25. Kandutsch A.A., and Chen H.W. Consequences of blocked sterol synthesis in cultured cells DNA synthesis and membrane composition. J Biol Chem 252 (1977) 409-415
26. Erickson S.K., Cooper A.D., Matsui S.M., and Gould R.G. 7-Ketocholeserol Its effects on hepatic cholesterogenesis and its hepatic metabolism in vivo and in vitro. J Biol Chem 252 (1977) 5186-5193
27. Taylor F.R., Saucier S.E., Shown E.P., Parish E.J., and Kandutsch A.A. Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. J Biol Chem 259 (1984) 12382-12387
28. Olkkonen V.M., and Lehto M. Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis. Ann Med 36 (2004) 562-572
29. Suchanek M., Hynynen R., Wohlfahrt G., Lehto M., Johansson M., Saarinen H., et al. The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-hydroxycholesterol in an evolutionarily conserved pocket. Biochem J 405 (2007) 473-480
30. Nishimura T., Inoue T., Shibata N., Sekine A., Takabe W., Noguchi N., et al. Inhibition of cholesterol biosynthesis by 25-hydroxycholesterol is independent of OSBP. Genes Cells 10 (2005) 793-801
31. Adams C.M., Reitz J., De Brabander J.K., Feramisco J.D., Li L., Brown M.S., et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J Biol Chem 279 (2004) 52772-52780
32. Brown A.J., Sun L., Feramisco J.D., Brown M.S., and Goldstein J.L. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 10 (2002) 237-245
33. Zhang Z., Li D., Blanchard D.E., Lear S.R., Erickson S.K., and Spencer T.A. Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations. J Lipid Res 42 (2001) 649-658
34. Björkhem I., and Diczfalusy U. 24(S),25-epoxycholesterol - a potential friend. Arterioscler Thromb Vasc Biol 24 (2004) 2209-2210
35. Erickson K.A., and Nes W.R. Inhibition of hepatic cholesterol synthesis in mice by sterols with shortened and stereochemically varied side chains. Proc Natl Acad Sci USA 79 (1982) 4873-4877
36. Lund E., and Björkhem I. Role of oxysterols in the regulation of cholesterol homeostasis: a critical evaluation. Acc Chem Res 28 (1995) 241-250
37. Li-Hawkins J., Lund E.G., Turley S.D., and Russell D.W. Disruption of the oxysterol 7α-hydroxylase gene in mice. J Biol Chem (2000) 16536-16542
38. Rosen H., Reshef A., Maeda N., Lippoldt A., Shpizen S., Triger L., et al. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem 273 (1998) 14805-14812
39. Björkhem I. Do oxysterols control cholesterol homeostasis?. J Clin Invest 110 (2002) 725-730
40. Clare K., Hardwick S.J., Carpenter K.L., Weeratunge N., and Mitchinson M.J. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis 118 (1995) 67-75
41. Björkhem I., and Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers?. Arterioscler Thromb Vasc Biol 22 (2002) 734-742
42. Briggs M.R., Yokoyama C., Wang X., Brown M.S., and Goldstein J.L. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 268 (1993) 14490-14496
43. Wang X., Sato R., Brown M.S., Hua X., and Goldstein J.L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77 (1994) 53-62
44. Goldstein J.L., DeBose-Boyd R.A., and Brown M.S. Protein sensors for membrane sterols. Cell 124 (2006) 35-46
45. Adams C.M., Goldstein J.L., and Brown M.S. Cholesterol-induced conformational change in SCAP enhanced by Insig proteins and mimicked by cationic amphiphiles. Proc Natl Acad Sci U S A 100 (2003) 10647-10652
46. Radhakrishnan A., Sun L.P., Kwon H.J., Brown M.S., and Goldstein J.L. Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol Cell 15 (2004) 259-268
47. Radhakrishnan A., Ikeda Y., Kwon H.J., Brown M.S., and Goldstein J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci USA 104 (2007) 6511-6518
48. Sever N., Yang T., Brown M.S., Goldstein J.L., and DeBose-Boyd R.A. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 11 (2003) 25-33
49. Willy P.J., and Mangelsdorf D.J. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev 11 (1997) 289-298
50. Cummins C.L., and Mangelsdorf D.J. Liver X receptors and cholesterol homoeostasis: spotlight on the adrenal gland. Biochem Soc Trans 34 (2006) 1110-1113
51. Gelissen I.C., Harris M., Rye K.-A., Quinn C., Brown A.J., Kockx M., et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to ApoA-I. Arterioscler Thromb Vasc Biol 26 (2006) 534-540
52. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272 (1997) 3137-3140
53. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., et al. Structural requirements of ligands for the oxysterol liver X receptors LXR-α and LXR-β. Proc Natl Acad Sci USA 96 (1999) 266-271
54. Svensson S., Ostberg T., Jacobsson M., Norstrom C., Stefansson K., Hallen D., et al. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. Embo J 22 (2003) 4625-4633
55. Yang C., McDonald J.G., Patel A., Zhang Y., Umetani M., Xu F., et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem 281 (2006) 27816-27826
56. Chen W., Chen G., Head D.L., Mangelsdorf D.J., and Russell D.W. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab 5 (2007) 73-79
57. Wong J., Quinn C.M., Gelissen I.C., and Brown A.J. Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis. J Biol Chem 283 (2008) 700-707
58. Sone H., Shimano H., Shu M., Nakakuki M., Takahashi A., Sakai M., et al. Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages. Biochem Biophys Res Commun 316 (2004) 790-794
59. Wong J., Quinn C.M., Gelissen I.C., Jessup W., and Brown A.J. The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation. Atherosclerosis 196 (2008) 180-189
60. Wong J., Quinn C.M., and Brown A.J. Statins inhibit synthesis of an oxysterol ligand for the liver X receptor in human macrophages with consequences for cholesterol flux. Arterioscler Thromb Vasc Biol 24 (2004) 2365-2371
61. Wong J., Quinn C.M., and Brown A.J. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1 by generating oxysterol ligands for LXR. Biochem J 400 (2006) 485-491
62. Nelson J.A., Steckbeck S.R., and Spencer T.A. Biosynthesis of 24,25-epoxycholesterol from squalene 2,3;22,23-dioxide. J Biol Chem 256 (1981) 1067-1068
63. Spencer T.A., Gayen A.K., Phirwa S., Nelson J.A., Taylor F.R., Kandutsch A.A., et al. 24(S),25-Epoxycholesterol, evidence consistent with a role in the regulation of hepatic cholesterogenesis. J Biol Chem 260 (1985) 13391-13394
64. Janowski B.A., Shan B., and Russell D.W. The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols. J Biol Chem 276 (2001) 45408-45416
65. Rowe A.H., Argmann C.A., Edwards J.Y., Sawyez C.G., Morand O.H., Hegele R.A., et al. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circ Res 93 (2003) 717-725
66. Song B.-L., and DeBose-Boyd R.A. Ubiquitination of 3-hydroxy-3-methylglutaryl CoA reductase in permeabilized cells mediated by cytosolic E1 and a putative membrane-bound ubiquitin ligase. J Biol Chem 279 (2004) 28798-28806
67. Wong J., Quinn C.M., Guillemin G., and Brown A.J. Primary human astrocytes produce 24(S),25-epoxycholesterol with implications for brain cholesterol homeostasis. J Neurochem 103 (2007) 1764-1773
68. Wong J., Quinn C.M., and Brown A.J. Synthesis of the oxysterol, 24(S), 25-epoxycholesterol, parallels cholesterol production and may protect against cellular accumulation of newly-synthesized cholesterol. Lipids Health Dis 6 (2007) 10
69. Dollis D., and Schuber F. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor, 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2. Biochem Pharmacol 48 (1994) 49-57
70. Mark M., Muller P., Maier R., and Eisele B. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells. J Lipid Res 37 (1996) 148-158
71. Beyea M.M., Heslop C.L., Sawyez C.G., Edwards J.Y., Markle J.G., Hegele R.A., et al. Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol. J Biol Chem 282 (2007) 5207-5216
72. Feng B., Yao P.M., Li Y., Devlin C.M., Zhang D., Harding H.P., et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 5 (2003) 781-792
73. Panini S.R., Delate T.A., and Sinensky M. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 24(S),25-oxidolanosterol. J Biol Chem 267 (1992) 12647-12654
74. Heverin M., Meaney S., Brafman A., Shafir M., Olin M., Shafaati M., et al. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol. Arterioscler Thromb Vasc Biol 27 (2007) 2191-2197
75. Dennick R.G., Dean P.D., and Abramovich D.A. Desmosterol levels in human foetal brain - a reassessment. J Neurochem 20 (1973) 1293-1294
76. Song B.-L., Javitt N.B., and DeBose-Boyd R.A. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab 1 (2005) 179-189
77. Nguyen A.D., McDonald J.G., Bruick R.K., and DeBose-Boyd R.A. Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A Reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of Insigs. J Biol Chem 282 (2007) 27436-27446
78. Hughes A.L., Todd B.L., and Espenshade P.J. SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell 120 (2005) 831-842
79. Hughes A.L., Lee C.-Y.S., Bien C.M., and Espenshade P.J. 4-Methyl sterols regulate fission yeast SREBP-Scap under low oxygen and cell stress. J Biol Chem 282 (2007) 24388-24396
80. Vaupel P., and Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26 (2007) 225-240
81. Yamauchi M., and Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal 10 (2008) 755-769
82. Björkhem I., and Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24 (2004) 806-815
83. Gelissen I.C., Brown A.J., Mander E.L., Kritharides L., Dean R.T., and Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem 271 (1996) 17852-17860
84. Björkhem I., Lütjohann D., Diczfalusy U., Stahle L., Ahlborg G., and Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 39 (1998) 1594-1600
85. Lund E., Andersson O., Zhang J., Babiker A., Ahlborg G., Diczfalusy U., et al. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arteriosclerosis, thrombosis, and vascular biology 16 (1996) 208-212
86. Babiker A., Andersson O., Lindblom D., van der Linden J., Wiklund B., Lütjohann D., et al. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J Lipid Res 40 (1999) 1417-1425
87. Björkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R.J., Duan C., et al. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA 91 (1994) 8592-8596
88. Tam S.-P., Mok L., Chimini G., Vasa M., and Deeley R.G. ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells. Am J Physiol Cell Physiol 291 (2006) 490-502
89. Engel T., Kannenberg F., Fobker M., Nofer J.-R., Bode G., Lueken A., et al. Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7β-hydroxycholesterol. FEBS Letters 581 (2007) 1673-1680
90. Terasaka N., Wang N., Yvan-Charvet L., and Tall A.R. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci USA 104 (2007) 15093-15098
91. Dzeletovic S., Breuer O., Lund E., and Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 225 (1995) 73-80
92. Brown A.J., Watts G.F., Burnett J.R., Dean R.T., and Jessup W. Sterol 27-hydroxylase acts on 7-ketocholesterol in human atherosclerotic lesions and macrophages in culture. J Biol Chem 275 (2000) 27627-27633
93. Lyons M.A., and Brown A.J. Metabolism of an oxysterol, 7-ketocholesterol, by sterol 27-hydroxylase in HepG2 cells. Lipids 36 (2001) 701-711
94. Lee J.W., Fuda H., Javitt N.B., Strott C.A., and Rodriguez I.R. Expression and localization of sterol 27-hydroxylase (CYP27A1) in monkey retina. Exp Eye Res 83 (2006) 465-469
95. Knabe C., Sudhop T., von Bergmann K., and Lütjohann D. Degradation of 24S-hydroxycholesterol in men is not regulated by CYP7A1. Int J Clin Pharmacol Ther 45 (2007) 577-583
96. Schweizer R.A.S., Zurcher M., Balazs Z., Dick B., and Odermatt A. Rapid hepatic metabolism of 7-ketocholesterol by 11β-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human and hamster enzyme. J Biol Chem 279 (2004) 18415-18424
97. Larsson H., Bottiger Y., Iuliano L., and Diczfalusy U. In vivo interconversion of 7β-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radical Biol Med 43 (2007) 695-701
98. Fuda H., Javitt N.B., Mitamura K., Ikegawa S., and Strott C.A. Oxysterols are substrates for cholesterol sulfotransferase. J Lipid Res 48 (2007) 1343-1352
99. Meloche C.A., and Falany C.N. Expression and characterization of the human 3β-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b). J Steroid Biochem Mol Biol 77 (2001) 261-269
100. Shimizu C., Fuda H., Yanai H., and Strott C.A. Conservation of the hydroxysteroid sulfotransferase SULT2B1 gene structure in the mouse: pre- and post-natal expression, kinetic analysis of isoforms, and comparison with prototypical SULT2A1. Endocrinology 144 (2003) 1186-1193
101. Li T., Chen W., and Chiang J.Y.L. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res 48 (2007) 373-384
102. Ren S., Li X., Rodriguez-Agudo D., Gil G., Hylemon P., and Pandak W.M. Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes. Biochem Biophys Res Commun 360 (2007) 802-808
103. Song C., Hiipakka R.A., and Liao S. Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis. Steroids 66 (2001) 473-479
104. Gustafsson J.A., Shackleton C.H., and Sjovall J. Steroids in newborns and infants C19 and C21 steroids in faeces from infants. Eur J Biochem 10 (1969) 302-311
105. Meng L.J., Griffiths W.J., Nazer H., Yang Y., and Sjovall J. High levels of (24S)-24-hydroxycholesterol 3-sulfate, 24-glucuronide in the serum and urine of children with severe cholestatic liver disease. J Lipid Res 38 (1997) 926-934
106. Cases S., Novak S., Zheng Y.-W., Myers H.M., Lear S.R., Sande E., et al. ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase its cloning, expression, and characterization. J Biol Chem 273 (1998) 26755-26764
107. Chang T.Y., Chang C.C., Ohgami N., and Yamauchi Y. Cholesterol sensing, trafficking, and esterification. Annu Rev Cell Dev Biol 22 (2006) 129-157
108. Brown M.S., Dana S.E., and Goldstein J.L. Cholesterol ester formation in cultured human fibroblasts Stimulation by oxygenated sterols. J Biol Chem 250 (1975) 4025-4027
109. Lange Y., and Steck T.L. Quantitation of the pool of cholesterol associated with acyl-CoA:cholesterol acyltransferase in human fibroblasts. J Biol Chem 272 (1997) 13103-13108
110. Du X., Kristiana I., Wong J., and Brown A.J. Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol Biol Cell 17 (2006) 2735-2745
111. Du X., Pham Y.H., and Brown A.J. Effects of 25-hydroxycholesterol on cholesterol esterification and SREBP processing are dissociable: Implications for cholesterol movement to the regulatory pool in the endoplasmic reticulum. J Biol Chem 279 (2004) 47010-47016
112. Chang T.-Y., Reid P.C., Sugii S., Ohgami N., Cruz J.C., and Chang C.C.Y. Niemann-Pick type C disease and intracellular cholesterol trafficking. J Biol Chem 280 (2005) 20917-20920
113. Pentchev P.G., Comly M.E., Kruth H.S., Vanier M.T., Wenger D.A., Patel S., et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci USA 82 (1985) 8247-8251
114. Liscum L., and Faust J.R. Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts. J Biol Chem 262 (1987) 17002-17008
115. Frolov A., Zielinski S.E., Crowley J.R., Dudley-Rucker N., Schaffer J.E., and Ory D.S. NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols. J Biol Chem 278 (2003) 25517-25525
116. Infante R.E., Abi-Mosleh L., Radhakrishnan A., Dale J.D., Brown M.S., and Goldstein J.L. Purified NPC1 protein: I Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein. J Biol Chem 283 (2007) 1052-1063
117. Xie C., Lund E.G., Turley S.D., Russell D.W., and Dietschy J.M. Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J Lipid Res 44 (2003) 1780-1789
118. Lum L., and Beachy P.A. The Hedgehog response network: sensors, switches, and routers. Science 304 (2004) 1755-1759
119. Brown A.J. Cholesterol, statins and cancer. Clin Exper Pharm Physiol 34 (2007) 135-141
120. Dwyer J.R., Sever N., Carlson M., Nelson S.F., Beachy P.A., and Parhami F. Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J Biol Chem 282 (2007) 8959-8968
121. Corcoran R.B., and Scott M.P. Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci USA 103 (2006) 8408-8413
122. Rohatgi R., Milenkovic L., and Scott M.P. Patched1 regulates hedgehog signaling at the primary cilium. Science 317 (2007) 372-376
123. Singla V., and Reiter J.F. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science 313 (2006) 629-633
124. Engelking L.J., Evers B.M., Richardson J.A., Goldstein J.L., Brown M.S., and Liang G. Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin. J Clin Invest 116 (2006) 2356-2365
125. Javitt N.B. Oxysterols: functional significance in fetal development and the maintenance of normal retinal function. Curr Opin Lipidol 18 (2007) 283-289
126. Deng R., Yang D., Yang J., and Yan B. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor Farsenoid X Receptor but not Liver X Receptor. J Pharmacol Exp Ther 317 (2006) 317-325
127. Lala D.S., Syka P.M., Lazarchik S.B., Mangelsdorf D.J., Parker K.L., and Heyman R.A. Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc Natl Acad Sci USA 94 (1997) 4895-4900
128. Christenson L.K., McAllister J.M., Martin K.O., Javitt N.B., Osborne T.F., and Strauss III J.F. Oxysterol regulation of steroidogenic acute regulatory protein gene expression structural specificity and transcriptional and posttranscriptional actions. J Biol Chem 273 (1998) 30729-30735
129. DuSell C.D., Umetani M., Shaul P.W., Mangelsdorf D.J., and McDonnell D.P. 27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol 22 (2008) 65-77
130. Umetani M., Domoto H., Gormley A.K., Yuhanna I.S., Cummins C.L., Javitt N.B., et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med 13 (2007) 1185-1192
131. Diestel A., Aktas O., Hackel D., Hake I., Meier S., Raine C.S., et al. Activation of microglial Poly(ADP-Ribose)-Polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J Exp Med 198 (2003) 1729-1740
132. Leoni V., Lütjohann D., and Masterman T. Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J Lipid Res 46 (2005) 191-195
133. Lütjohann D. Cholesterol metabolism in the brain: importance of 24S-hydroxylation. Acta Neurol Scand Suppl 114 (2006) 33-42
134. Lütjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U., et al. Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 93 (1996) 9799-9804
135. Carpenter K.L.H., Taylor S.E., van der Veen C., Williamson B.K., Ballantine J.A., and Mitchinson M.J. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim Biophys Acta Lipids Lipid Metabol 1256 (1995) 141-150
136. Brown A.J., Dean R.T., and Jessup W. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. J Lipid Res 37 (1996) 320-335
137. Vine D.F., Mamo J.C.L., Beilin L.J., Mori T.A., and Croft K.D. Dietary oxysterols are incorporated in plasma triglyceride-rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration of rabbits. J Lipid Res 39 (1998) 1995-2004
138. Brown A.J., Leong S.L., Dean R.T., and Jessup W. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J Lipid Res 38 (1997) 1730-1745
139. McDonald J., Thompson B., McCrum E., and Russell D.W. Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry. Methods Enzymol 432 (2007) 145-170
140. Karu K., Hornshaw M., Woffendin G., Bodin K., Hamberg M., Alvelius G., et al. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J Lipid Res 48 (2007) 976-987
141. Lund E.G., and Dizcfaluzy U. Quantitation of receptor ligands by mass spectrometry. Methods Enzymol 364 (2003) 24-37
142. Di Frisco S., De Ruggieri P., and Ercoli A. Isolation of cerebrosterol from human brain. Bollettino della Societa italiana di biologia sperimentale 29 (1953) 1351-1352
143. Fredrickson D.S., and Ono K. The in vitro production of 25- and 26-hydroxycholesterol and their in vivo metabolism. Biochim Biophys Acta 22 (1956) 183-184
144. Lütjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U., et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 93 (1996) 9799-9804